PLK4 and osteosarcoma: This was attributed to NF-κB, which directly targets PLK4 and plays a crucial role in osteosarcoma cell proliferation, an important regulatory pathway which is involved in a variety of cellular processes including inflammatory and immune responses, cellular death, stress, adhesion and progression.